Primary Site Surgery in Distantly Metastatic Oropharyngeal Squamous Cell Carcinoma
The Laryngoscope · 2024
DOI: 10.1002/lary.31177 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Ryan M Carey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Oropharyngeal Neoplasms, Papillomavirus Infections, Head and Neck Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: McCabe Foundation Fellowship Grant.
Abstract (Originalsprache)
Objectives
Determine if intensive local therapy (i.e., local surgery or radiation) has a survival benefit for patients presenting with distantly metastatic oropharyngeal squamous cell carcinoma (OPSCC).
Methods
Retrospective population‐based cohort study of patients in the National Cancer Database presenting with distantly metastatic OPSCC. Overall survival (OS) was compared for patients receiving systemic therapy alone or in combination with local surgery or curative dose radiation, controlling for various clinicodemographic factors.
Results
Between 2010 and 2015, 627 patients presented with newly diagnosed, metastatic OPSCC and an initial treatment course including systemic chemotherapy. Multivariable analysis demonstrated that local radiation therapy was independently associated with improved OS (OR 0.64, CI [0.51–0.81]); local surgery was not independently associated with improved OS (OR 0.99, CI [0.65–1.53]). Higher T stages were associated with worse OS (OR 1.69, CI [1.14–2.50] for T3 and OR 1.77, CI [1.22–2.58] for T4 compared to T1). HPV‐positive (HPV+) tumors were associated with improved OS compared to HPV‐ (OR 0.79, CI [0.64–0.97]). Multiagent chemotherapy was associated with improved OS compared to single‐agent (OR 0.78, CI [0.62–1.00]). The best survival for the entire cohort and for HPV+ patients was for radiation with systemic therapy and the worst survival for systemic therapy alone.
Conclusions
Curative dose local radiotherapy in addition to systemic therapy is associated with improved OS compared to systemic therapy alone in patients presenting with distantly metastatic OPSCC. There is not a significant survival benefit for local surgery in addition to systemic therapy in this patient population, regardless of HPV status. Level of Evidence 3 Laryngoscope , 134:2243–2251, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Otolaryngology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.
- Department of Otolaryngology-Head & Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Ryan M Carey, Aman Prasad, Jason A Brant, Robert M Brody, Francisco J Civantos, Larissa Sweeny
Förderung
- McCabe Foundation Fellowship Grant
Zitieren
APA
Carey, R. M., Prasad, A., Wei, K., Brant, J. A., Brody, R. M., Leibowitz, J. M., Civantos, F. J., & Sweeny, L. (2024). Primary Site Surgery in Distantly Metastatic Oropharyngeal Squamous Cell Carcinoma. The Laryngoscope. https://doi.org/10.1002/lary.31177
Vancouver
Carey RM, Prasad A, Wei K, Brant JA, Brody RM, Leibowitz JM, et al. Primary Site Surgery in Distantly Metastatic Oropharyngeal Squamous Cell Carcinoma. The Laryngoscope. 2024. doi:10.1002/lary.31177
BibTeX
@article{Carey2024,
author = {Carey, Ryan M and Prasad, Aman and Wei, Kimberly and Brant, Jason A and Brody, Robert M and Leibowitz, Jason M and Civantos, Francisco J and Sweeny, Larissa},
title = {Primary Site Surgery in Distantly Metastatic Oropharyngeal Squamous Cell Carcinoma},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31177}
}
EUVIMED